21st Austria weekly - Valneva Pierer Mobility 16/09/2022 [pic1]Valneva: an Austrian/French specialty vaccine company and IDT Biologika today announced they have agreed to terminate their collaboration following the delivery of inactivated COVID-19 bulk considering current order levels existing inventories. In light reduced European Commission order Valneva has suspended manufacturing and as compensation will pay up Euro 36.2 mn in cash equivalent 4.5 kind form specified equipment purchased by Valneva.As per commercial services agreement signed November 2021 produced VLA2001 at its Biosafety Level
Washington, DC The nation’s leading wildlife disease laboratory has committed to obtaining independent accreditation, according to a message sent to Public Employees for Environmental Responsibility (PEER) by U.S.Geological Survey (USGS) Director Applegate.
Dakar, Senegal (PANA) – Senegalese legislators have passed a new biosafety law establishing a process to allow the entry, research, and commercialization of genetically engineered (GE) products in the West African country